Skip to Main Content

INFORMATION FOR

EPIC-P Intervention

Conditions

Infectious Diseases | Men's Health | Women's Health

What is the purpose of this trial?

This non-randomized, open-label study will address the following research aims in People who inject drugs (PWID):

  • To assess the feasibility and acceptability of the Expanding PrEP Implementation in Communities of PWID (EPIC-P) intervention among high-risk PWID.
  • To determine the preliminary efficacy of the EPIC-P intervention in terms of increasing adherence to PrEP and primary HIV prevention among high-risk PWID.
  • Trial with
    Yale University School of Medicine
  • Start Date
    01/06/2020
  • End Date
    03/15/2023

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    11/11/2022
  • Study HIC
    #2000026228